Technology

  Market Overview According to MarketGenics , the global Biopharmaceuticals Market is valued at USD 447.2 billion in 2025 and is projected to reach USD  839.4 billion by 2035 , registering a CAGR of 6.5% during the forecast period. The market is experiencing robust growth due to the increasing demand for biologic therapies, rising prevalence of chronic and rare diseases, and continuous advancements in biotechnology. Biopharmaceuticals, including monoclonal antibodies, recombinant proteins, vaccines, cell and gene therapies, blood products, and biosimilars, have become essential in treating complex diseases such as cancer, autoimmune disorders, diabetes, neurological diseases, and infectious diseases. Technological innovations in bioprocessing, precision medicine, genomics, and artificial intelligence-driven drug development are accelerating the discovery and commercialization of next-generation biologics. Growing investments in biotechnology research, expanding manuf...